DRI-C25441 is a potent blocker of CD40 and CD40L interaction, with an IC50 of 0.36 µM. DRI-C25441 can inhibit the immune response induced by alloantigen. can inhibit CD40L induced activation of NF-kappaB signaling pathway. DRI-C25441 commonly is used in research on immune conditions [1][2].
Molekulargewicht:
531.51
Reinheit:
99.53
CAS Nummer:
[2101765-83-5]
Formel:
C31H21N3O6
Target-Kategorie:
NF-kappaB,TNF Receptor
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten